TrialThe Lancet. Respiratory medicine2022

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial.

E Wesley Ely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.